Alzheimer's disease (AD) as a disorder of the plasma membrane

Frontiers in Physiology

Volumn 4 FEB, Issue , 2013, Pages

  Lukiw, Walter J ^a  

^a LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SECRETASE; AMYLOID BETA PROTEIN[1-42]; AMYLOID PRECURSOR PROTEIN; BETA SECRETASE; DOCOSAHEXAENOIC ACID; GAMMA SECRETASE; MICRORNA; PHOSPHOLIPID;

ALZHEIMER DISEASE; CELL MEMBRANE; EXOCYTOSIS; EXOSOME; HUMAN; LIPID RAFT; MEMBRANE STRUCTURE; NEUROFIBRILLARY TANGLE; NOTE; PHOSPHOLIPID MEMBRANE; PROTEIN AGGREGATION; PROTEIN PROCESSING; SENILE PLAQUE;

EID: 84883750935     PISSN: None     EISSN: 1664042X     Source Type: Journal    
DOI: 10.3389/fphys.2013.00024     Document Type: Note

References (19)

1. Alexandrov, P. N., Dua, P., Hill, J. M., Bhattacharjee, S., Zhao, Y., and Lukiw, W. J. (2012). microRNA (miRNA) speciation in Alzheimer's disease (AD) cerebrospinal fluid (CSF) and extracellular fluid (ECF). Int. J. Biochem. Mol. Biol. 3, 365-373.
2. Alzheimer, A., Stelzmann, R. A., Schnitzlein, H. N., and Murtagh, F. R. (1995). An English translation of Alzheimer's 1907 paper "Uber eine eigenartige Erkankung der Hirnrinde." Clin. Anat. 8, 429-431.
3. Alzheimer Association. (2012). Alzheimer's disease facts and figures; a statistical resource. Available online at: http://www.alz.org/downloads/Facts_Figures_2012.pdf
4. Ball, M. J., Lukiw, W. J., Kammerman, E. M., and Hill, J. M. (2012). Intracerebral propagation of Alzheimer's disease: strengthening evidence of a herpes simplex virus etiology. Alzheimers Dement. pii: S1552-5260(12)02420-X. doi: 10.1016/j.jalz.2012.07.005. [Epub ahead of print].
5. Fais, S., Logozzi, M., Lugini, L., Federici, C., Azzarito, T., Zarovni, N., et al. (2013). Exosomes: the ideal nanovectors for biodelivery. Biol. Chem. 394, 1-15.
6. Heneka, M. T., O'Banion, M. K., Terwel, D., and Kummer, M. P. (2010). Neuroinflammatory processes in Alzheimer's disease. J. Neural Transm. 117, 919-947.
7. Hicks, D. A., Nalivaeva, N. N., and Turner, A. J. (2012). Lipid rafts and Alzheimer's disease: protein-lipid interactions and perturbation of signaling. Front. Physiol. 3:189. doi: 10.3389/fphys.2012.00189
8. Kania, E., Pajak, B., Gajkowska, B., and Orzechowski, A. (2012). Lipid rafts in Alzheimer's disease. Postepy Biochem. 58, 209-216.
9. Kosicek, M., and Hecimovic, S. (2013). Phospholipids and Alzheimer's disease: alterations, mechanisms and potential biomarkers. Int. J. Mol. Sci. 14, 1310-1322.
10. Lukiw, W. J., and Bazan, N. G. (2010). Inflammatory, apoptotic, and survival gene signaling in Alzheimer's disease. A review on the bioactivity of neuroprotectin D1 and apoptosis. Mol. Neurobiol. 42, 10-16.
11. Lukiw, W. J. (2012a). Amyloid beta (Aß) peptide modulators and other current treatment strategies for Alzheimer's disease (AD). Expert Opin. Emerg. Drugs. PMID: 22439907. [Epub ahead of print].
12. Lukiw, W. J. (2012b). NF-ΚB-regulated micro RNAs (miRNAs) in primary human brain cells. Exp. Neurol. 235, 484-490.
13. Lukiw, W. J. (2012c). Evolution and complexity of micro RNA in the human brain. Front. Genet. 3:166. doi: 10.3389/fgene.2012.00166
14. Lukiw, W. J., Alexandrov, P. N., Zhao, Y., Hill, J. M., and Bhattacharjee, S. (2012). Spreading of Alzheimer's disease inflammatory signaling through soluble micro-RNA. Neuroreport 23, 621-626.
15. Niemitz, E. (2012). TREM2 and Alzheimer's disease. Nat. Genet. 45, 11.
16. Orth, M., and Bellosta, S. (2012). Cholesterol: its regulation and role in central nervous system disorders. Cholesterol 2012:292598. doi: 10.1155/2012/292598
17. Pallesen, L. T., and Vaegter, C. B. (2012). Sortilin and SorLA regulate neuronal sorting of trophic and dementia-linked proteins. Mol. Neurobiol. 45, 379-387.
18. Singaraja, R. R. (2013). TREM2: a new risk factor for Alzheimer's disease. Clin. Genet. doi: 10.1111/cge.12108. [Epub ahead of print].
19. Xu, D., Sharma, C., and Hemler, M. E. (2009). Tetraspanin12 regulates ADAM10-dependent cleavage of amyloid precursor protein. FASEB J. 23, 3674-3681.